Home › Companies › Korro Bio, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Korro Bio, Inc.’s Form 8-K, filed June 11, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of June 10, 2026: 4 items on Korro Bio, Inc.’s Form 8-K, filed June 11, 2026: 2 elected · 2 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore Korro Bio, Inc. in the interactive database Compare manager voting policies
These tallies are Korro Bio, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Nessan Bermingham | 7,468,003 | -- | -- | 1,576,660 | 1,875,955 | 83% | Elected | — |
| Elect Director: Rachel Meyers | 7,368,284 | -- | -- | 1,676,379 | 1,875,955 | 81% | Elected | — |
| Proposal 2: Korro's stockholders approved, in a non-binding, advisory vote, the compensation of Korro's named executive officers. | 9,009,739 | 27,988 | 6,936 | -- | 1,875,955 | 99.6% | Approved | — |
| Proposal 3: Korro's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026. | 10,917,621 | 2,738 | 259 | -- | 0 | 99.9% | Approved | — |
Source: Korro Bio, Inc., Form 8-K, filed with the SEC on June 11, 2026 — read the filing on EDGAR.
Each item below shows how the 124 asset managers that disclosed a Korro Bio, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: Election of two Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Nessan Bermingham
Korro Bio, Inc.’s own tally for this item (“Elect Director: Nessan Bermingham”): 7,468,003 for, 1,576,660 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “1) Korro's stockholders elected each of Nessan Bermingham and Rachel Meyers as Class I directors, each for a three-year term ending at the annual meeting of stockholders to be held in 2029 and each until his or her respective successor has been duly elected and qualified or until his or her earlier…”
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 484,351 for, 298,983 withheld, 3 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 322,725 | 0 | 3 | 0 | For |
| Fidelity | 126,217 | 0 | 0 | 32,866 | Mixed |
| BlackRock | 0 | 0 | 0 | 155,153 | Withhold |
| RBB FUND, INC. | 0 | 0 | 0 | 62,855 | Withhold |
| Charles Schwab | 13,378 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 10,341 | Withhold |
| TIAA | 0 | 0 | 0 | 8,283 | Withhold |
| Dimensional | 0 | 0 | 0 | 7,762 | Withhold |
| Equitable | 4,760 | 0 | 0 | 2,026 | Mixed |
| T. Rowe Price | 0 | 0 | 0 | 5,878 | Withhold |
| Lincoln Financial | 4,500 | 0 | 0 | 0 | For |
| Northern Trust | 4,391 | 0 | 0 | 0 | For |
| Goldman Sachs | 3,290 | 0 | 0 | 0 | For |
| Global X | 3,242 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 3,058 | Withhold |
| Bridge Builder Trust | 0 | 0 | 0 | 2,830 | Withhold |
| Pacific Life | 0 | 0 | 0 | 2,438 | Withhold |
| John Hancock | 0 | 0 | 0 | 1,998 | Withhold |
| Nationwide | 298 | 0 | 0 | 704 | Mixed |
| DWS | 0 | 0 | 0 | 966 | Withhold |
| ProShares | 0 | 0 | 0 | 888 | Withhold |
| State Street | 620 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 598 | Withhold |
| Venerable Variable Insurance Trust | 549 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 0 | 245 | Withhold |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Combines 4 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Description as filed by funds: Election of two Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Rachel Meyers
Korro Bio, Inc.’s own tally for this item (“Elect Director: Rachel Meyers”): 7,368,284 for, 1,676,379 withheld, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “1) Korro's stockholders elected each of Nessan Bermingham and Rachel Meyers as Class I directors, each for a three-year term ending at the annual meeting of stockholders to be held in 2029 and each until his or her respective successor has been duly elected and qualified or until his or her earlier…”
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 516,773 for, 266,561 withheld, 3 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 322,725 | 0 | 3 | 0 | For |
| Fidelity | 159,083 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 155,153 | Withhold |
| RBB FUND, INC. | 0 | 0 | 0 | 62,855 | Withhold |
| Charles Schwab | 13,378 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 10,341 | Withhold |
| TIAA | 8,283 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 7,762 | Withhold |
| Equitable | 0 | 0 | 0 | 6,786 | Withhold |
| T. Rowe Price | 5,878 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 4,500 | Withhold |
| Northern Trust | 0 | 0 | 0 | 4,391 | Withhold |
| Goldman Sachs | 3,290 | 0 | 0 | 0 | For |
| Global X | 3,242 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 3,058 | Withhold |
| Bridge Builder Trust | 0 | 0 | 0 | 2,830 | Withhold |
| Pacific Life | 0 | 0 | 0 | 2,438 | Withhold |
| John Hancock | 0 | 0 | 0 | 1,998 | Withhold |
| Nationwide | 298 | 0 | 0 | 704 | Mixed |
| DWS | 0 | 0 | 0 | 966 | Withhold |
| ProShares | 0 | 0 | 0 | 888 | Withhold |
| State Street | 0 | 0 | 0 | 620 | Withhold |
| Calvert | 0 | 0 | 0 | 598 | Withhold |
| Venerable Variable Insurance Trust | 549 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 0 | 245 | Withhold |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: Non-Binding advisory vote to approve the compensation of our named executive officers;
Korro Bio, Inc.’s own tally for this item (“Proposal 2: Korro's stockholders approved, in a non-binding, advisory vote, the compensation of Korro's named executive officers.”): 9,009,739 for, 27,988 against — passed, per its Form 8-K filed June 11, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “2) Korro's stockholders approved, in a non-binding, advisory vote, the compensation of Korro's named executive officers.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 322,728 | 0 | 0 | 0 | For |
| Fidelity | 159,083 | 0 | 0 | 0 | For |
| BlackRock | 155,153 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 62,855 | 0 | 0 | 0 | For |
| Charles Schwab | 13,378 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 10,341 | 0 | 0 | 0 | For |
| TIAA | 8,283 | 0 | 0 | 0 | For |
| Dimensional | 0 | 7,762 | 0 | 0 | Against |
| Equitable | 6,786 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,878 | 0 | 0 | 0 | For |
| Lincoln Financial | 4,500 | 0 | 0 | 0 | For |
| Northern Trust | 4,391 | 0 | 0 | 0 | For |
| Goldman Sachs | 3,290 | 0 | 0 | 0 | For |
| Global X | 3,242 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,058 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 2,830 | 0 | 0 | 0 | For |
| Pacific Life | 2,438 | 0 | 0 | 0 | For |
| John Hancock | 1,998 | 0 | 0 | 0 | For |
| Nationwide | 1,002 | 0 | 0 | 0 | For |
| DWS | 966 | 0 | 0 | 0 | For |
| ProShares | 888 | 0 | 0 | 0 | For |
| State Street | 620 | 0 | 0 | 0 | For |
| Calvert | 598 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 549 | 0 | 0 | 0 | For |
| Principal | 245 | 0 | 0 | 0 | For |
Fund voting reports, all 31 managers: 775,551 for, 7,786 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 1,538,296 | 0 | 0 | 0 | For |
| NEA Management Company, LLC | 1,299,230 | 0 | 0 | 0 | For |
| Atlas Venture Life Science Advisors, LLC | 1,137,149 | 0 | 0 | 0 | For |
| Venrock Adviser, LLC | 1,009,500 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 450,045 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 347,718 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 299,036 | 0 | 0 | 0 | For |
| Point72 | 276,831 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 228,400 | 0 | 0 | 0 | For |
| AQR | 158,001 | 0 | 0 | 0 | For |
| Affinity Asset Advisors, LLC | 156,250 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 150,051 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 134,820 | 0 | 0 | 0 | For |
| State Street | 114,271 | 270 | 0 | 0 | For |
| BlackRock | 71,338 | 18 | 0 | 0 | For |
| Cornerstone National Bank & Trust Co | 56,674 | 0 | 0 | 0 | For |
| Two Sigma | 37,717 | 0 | 0 | 0 | For |
| Fidelity | 36,928 | 0 | 0 | 0 | For |
| Northern Trust | 31,730 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 30,852 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 27,255 | 0 | 0 | 0 | For |
| Vanguard | 23,161 | 0 | 0 | 0 | For |
| T. Rowe Price | 14,168 | 0 | 0 | 0 | For |
| Charles Schwab | 13,394 | 0 | 0 | 0 | For |
| Nuveen | 12,723 | 0 | 0 | 0 | For |
Institutional-manager reports, all 102 managers: 7,729,105 for, 9,684 against, 2,164 abstained. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;
Korro Bio, Inc.’s own tally for this item (“Proposal 3: Korro's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026.”): 10,917,621 for, 2,738 against — passed, per its Form 8-K filed June 11, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “3) Korro's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 783,337 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 322,728 | 0 | 0 | 0 | For |
| Fidelity | 159,083 | 0 | 0 | 0 | For |
| BlackRock | 155,153 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 62,855 | 0 | 0 | 0 | For |
| Charles Schwab | 13,378 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 10,341 | 0 | 0 | 0 | For |
| TIAA | 8,283 | 0 | 0 | 0 | For |
| Dimensional | 7,762 | 0 | 0 | 0 | For |
| Equitable | 6,786 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,878 | 0 | 0 | 0 | For |
| Lincoln Financial | 4,500 | 0 | 0 | 0 | For |
| Northern Trust | 4,391 | 0 | 0 | 0 | For |
| Goldman Sachs | 3,290 | 0 | 0 | 0 | For |
| Global X | 3,242 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,058 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 2,830 | 0 | 0 | 0 | For |
| Pacific Life | 2,438 | 0 | 0 | 0 | For |
| John Hancock | 1,998 | 0 | 0 | 0 | For |
| Nationwide | 1,002 | 0 | 0 | 0 | For |
| DWS | 966 | 0 | 0 | 0 | For |
| ProShares | 888 | 0 | 0 | 0 | For |
| State Street | 620 | 0 | 0 | 0 | For |
| Calvert | 598 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 549 | 0 | 0 | 0 | For |
| Principal | 245 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 14,422,571 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 2.24% |
| 2 | Fidelity | 1.10% |
| 3 | BlackRock | 1.08% |
| 4 | RBB FUND, INC. | 0.44% |
| 5 | Charles Schwab | 0.09% |
| 6 | QUANTITATIVE MASTER SERIES LLC | 0.07% |
| 7 | TIAA | 0.06% |
| 8 | Dimensional | 0.05% |
| 9 | Equitable | 0.05% |
| 10 | T. Rowe Price | 0.04% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Lynx1 Capital Management LP | 10.67% |
| 2 | NEA Management Company, LLC | 9.01% |
| 3 | Atlas Venture Life Science Advisors, LLC | 7.88% |
| 4 | Venrock Adviser, LLC | 7.00% |
| 5 | DRIEHAUS CAPITAL MANAGEMENT LLC | 3.12% |
| 6 | Siren, L.L.C. | 2.41% |
| 7 | Nantahala Capital Management, LLC | 2.07% |
| 8 | Point72 | 1.92% |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.58% |
| 10 | AQR | 1.10% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Lynx1 Capital Management LP | 10.67% | 13G |
| Venrock Healthcare Capital Partners III, L.P. | 10.32% | 13G |
| New Enterprise Associates 17, L.P. | 9.95% | 13D |
| BALYASNY ASSET MANAGEMENT L.P. | 6.60% | 13G |
| Steven A. Cohen | 5.66% | 13G |
| Atlas Venture Fund XI, L.P. | 4.90% | 13D |
| Vanguard Group | 3.39% | 13F |
| BlackRock | 3.19% | 13F |
| Point72 Biotech Private Investments, LLC | 1.92% | 13G |
| Citadel Advisors | 1.87% | 13F |
Percentages above are of 14,422,571 shares outstanding, as reported by Korro Bio, Inc. on its Form 10-Q dated May 4, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Korro Bio, Inc.’s 10-Q dated May 4, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At Korro Bio, Inc.'s shareholder meeting held June 10, 2026, in the 2025-2026 proxy season, 124 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 494 separate fund positions. On the most widely held item on that ballot — Non-Binding advisory vote to approve the compensation of our named executive officers; — Korro Bio, Inc.'s filing reports the proposal as approved, with 99.6% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Korro Bio, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 11, 2026.
Korro Bio, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.